Biotricity Financial Statements From 2010 to 2024
| BTCY Stock | USD 1.34 0.19 16.52% |
Gross Profit 4.6 M | Profit Margin (1.25) | Market Capitalization 12.9 M | Enterprise Value Revenue 2.9603 | Revenue 11.6 M |
Biotricity Total Revenue |
|
Check Biotricity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biotricity main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.5 K, Interest Expense of 2 M or Selling General Administrative of 21.3 M, as well as many exotic indicators such as Price To Sales Ratio of 0.46, Dividend Yield of 0.22 or Days Sales Outstanding of 74.99. Biotricity financial statements analysis is a perfect complement when working with Biotricity Valuation or Volatility modules.
Biotricity | Select Account or Indicator |
Biotricity Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biotricity Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biotricity Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biotricity Valuation Data | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biotricity Fundamental Market Drivers
| Cash And Short Term Investments | 570.5 K |
Biotricity Upcoming Events
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 4th of July 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of July 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
About Biotricity Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Biotricity income statement, its balance sheet, and the statement of cash flows. Biotricity investors use historical funamental indicators, such as Biotricity's revenue or net income, to determine how well the company is positioned to perform in the future. Although Biotricity investors may use each financial statement separately, they are all related. The changes in Biotricity's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biotricity's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Biotricity Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Biotricity. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 1.8 M | 1.9 M | |
| Total Revenue | 11.1 M | 11.6 M | |
| Cost Of Revenue | 4.8 M | 5.1 M | |
| Stock Based Compensation To Revenue | 0.08 | 0.07 | |
| Sales General And Administrative To Revenue | 2.10 | 2.00 | |
| Research And Ddevelopement To Revenue | 0.39 | 0.37 | |
| Capex To Revenue | (0) | (0) | |
| Revenue Per Share | 1.00 | 1.05 | |
| Ebit Per Revenue | (1.46) | (1.53) |
Pair Trading with Biotricity
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotricity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotricity will appreciate offsetting losses from the drop in the long position's value.Moving together with Biotricity Stock
| 0.61 | EHAB | Enhabit Financial Report 14th of May 2024 | PairCorr |
| 0.72 | COO | Cooper Companies Financial Report 6th of June 2024 | PairCorr |
Moving against Biotricity Stock
| 0.78 | FIGS | Figs Inc Financial Report 2nd of May 2024 | PairCorr |
| 0.74 | LUCY | Innovative Eyewear | PairCorr |
| 0.74 | MMSI | Merit Medical Systems Financial Report 24th of April 2024 | PairCorr |
| 0.62 | INNV | InnovAge Holding Corp Financial Report 14th of May 2024 | PairCorr |
| 0.58 | ACHC | Acadia Healthcare Financial Report 24th of April 2024 | PairCorr |
The ability to find closely correlated positions to Biotricity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotricity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotricity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotricity to buy it.
The correlation of Biotricity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotricity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotricity moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotricity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Biotricity Correlation against competitors. For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Biotricity Stock analysis
When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stocks Directory Find actively traded stocks across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Biotricity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.75) | Revenue Per Share 1.319 | Quarterly Revenue Growth 0.209 | Return On Assets (0.95) | Return On Equity (41.01) |
The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.